Posted in | News

Heraeus, Ferro Sign Business Acquisition Agreement

Heraeus and Ferro Corporation (NYSE:FOE) today announced that they have signed a definitive agreement to acquire from each other certain business lines concerning decoration materials for ceramic and glass products.

The agreement is subject to customary closing conditions; the companies expect the transactions to close by May 1, 2010.

“This transaction will enable both companies to offer their customers broadened technical service, more targeted products and greater innovation.”
.The Heraeus precious metals and technology group has agreed to acquire Ferro’s business operations in precious metal preparations and lustres for the decoration of glass, ceramics, porcelain and tiles. Heraeus has been in this business since 1896, and this acquisition will enhance its position as a market leader in precious metal preparations for the decoration industry.

Ferro, a producer of technology-based materials, will acquire Heraeus’ ceramic color business, which includes both lead-free and lead-containing colors for decorating glass, ceramics, porcelain and tiles. Ferro will also acquire the glazes, pigments and auxiliary businesses from Heraeus to further establish the company as a market leader in the ceramic colors industry.

Dieter Binder, Business Director of Ferro’s Performance Pigments and Colors business, explains, “With these acquisitions, both companies are focusing on their core competencies and areas of expertise.” Ralf Droste, Vice President of Thick Film Materials Division, Heraeus, says, “This transaction will enable both companies to offer their customers broadened technical service, more targeted products.

Source: http://www.ferro.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.